GLYCAN THERAPEUTICS CORPORATION SBIR Phase I Award, February 2023
A SBIR Phase I contract was awarded to Glycan Therapeutics in February, 2023 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Something went wrong.
Try refreshing the page.
Find more entities like GLYCAN THERAPEUTICS CORPORATION SBIR Phase I Award, February 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.